Abstract
The actinomycete Streptomyces sp. strain Gö40/10 has the potential to produce a range of secondary metabolites, one of which is collinolactone, a compound with neuroprotective properties and potential for pharmaceutical applications. The genome was sequenced with Oxford Nanopore Technologies MinION and Illumina MiSeq systems and consists of a single 9,635,564-nucleotide linear chromosome. The actinomycete Streptomyces sp. strain Gö40/10 has the potential to produce a range of secondary metabolites, one of which is collinolactone, a compound with neuroprotective properties and potential for pharmaceutical applications. The genome was sequenced with Oxford Nanopore Technologies MinION and Illumina MiSeq systems and consists of a single 9,635,564-nucleotide linear chromosome.
Cite
CITATION STYLE
Sterndorff, E. B., Jørgensen, T. S., Garzón, J. F. G., Schmid, J., Grond, S., & Weber, T. (2022). Complete Genome Sequence of the Collinolactone Producer Streptomyces sp. Strain Gö40/10. Microbiology Resource Announcements, 11(8). https://doi.org/10.1128/mra.00220-22
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
